Benito-Sanz Sara, Thomas N Simon, Huber Céline, Gorbenko del Blanco Darya, Aza-Carmona Miriam, Crolla John A, Maloney Vivienne, Rappold Gudrun, Argente Jesús, Campos-Barros Angel, Cormier-Daire Valérie, Heath Karen E
Department of Endocrinology, Hospital Infantil Universitario Nino Jesus, Universidad Autonoma de Madrid, Madrid, Spain.
Am J Hum Genet. 2005 Oct;77(4):533-44. doi: 10.1086/449313. Epub 2005 Aug 15.
Leri-Weill dyschondrosteosis (LWD) is a pseudoautosomal dominant disorder characterized by disproportionate short stature and a characteristic curving of the radius, known as the "Madelung deformity." SHOX mutations resulting in SHOX haploinsufficiency have been found in LWD and in a variable proportion of patients with idiopathic short stature (ISS), whereas homozygous loss of SHOX results in the more severe Langer mesomelic dysplasia (LMD). Defects in SHOX have been identified in approximately 60% of LWD cases, whereas, in the remaining approximately 40%, the molecular basis is unknown. This suggests either genetic heterogeneity or the presence of mutations in unanalyzed regions of SHOX, such as the upstream, intragenic, or downstream regulatory sequences. Therefore, the pseudoautosomal region 1 (PAR1) of 80 patients with LWD, in whom SHOX deletions and mutations had been excluded, was screened for deletions by use of a new panel of microsatellite markers. We identified 12 patients with LWD who presented with a novel class of PAR1 deletions that did not include SHOX. The deletions were of variable size and mapped at least approximately 30-530 kb downstream of SHOX. In our cohort, this type of deletion accounted for 15% of cases. In all cases, the deletions cosegregated with the phenotype. No apparent phenotypic differences were observed between patients with SHOX deletions and those with this new class of PAR1 deletions. Thus, we present here the identification of a second PAR1 region implicated in the etiopathogenesis of LWD. Our findings suggest the presence of distal regulatory elements of SHOX transcription in PAR1 or, alternatively, the existence of an additional locus apparently involved in the control of skeletal development. Deletion analysis of this newly identified region should be included in the mutation screening of patients with LWD, LMD, and ISS.
Leri-Weill软骨发育不全症(LWD)是一种拟常染色体显性疾病,其特征为身材不成比例矮小以及桡骨出现特征性弯曲,即“马德隆畸形”。在LWD以及一定比例的特发性矮小症(ISS)患者中发现了导致SHOX单倍剂量不足的SHOX突变,而SHOX纯合缺失则导致更为严重的Langer中肢发育不良(LMD)。在大约60%的LWD病例中已鉴定出SHOX缺陷,而在其余约40%的病例中,分子基础尚不清楚。这表明要么存在遗传异质性,要么在SHOX未分析区域(如上游、基因内或下游调控序列)存在突变。因此,对80例已排除SHOX缺失和突变的LWD患者的拟常染色体区域1(PAR1),使用一组新的微卫星标记进行缺失筛查。我们鉴定出12例LWD患者,他们呈现出一类不包括SHOX的新型PAR1缺失。这些缺失大小各异,定位在SHOX下游至少约30 - 530 kb处。在我们的队列中,这种类型的缺失占病例的15%。在所有病例中,缺失与表型共分离。在有SHOX缺失的患者和有这类新型PAR1缺失的患者之间未观察到明显的表型差异。因此,我们在此报告鉴定出与LWD发病机制相关的第二个PAR1区域。我们的发现表明PAR1中存在SHOX转录的远端调控元件,或者存在另一个显然参与骨骼发育控制的位点。对这个新鉴定区域的缺失分析应纳入LWD、LMD和ISS患者的突变筛查中。